Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) — Stella

Home/Chronic Thromboembolic Pulmonary Hypertension/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Thromboembolic Pulmonary Hypertension trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

China

Beijing Chao-Yang Hospital, Beijing, China

China-Japan Friendship Hospital, Beijing, China

Beijing Anzhen Hospital, Beijing, China

Key details

Phase

Large-scale testing

Sponsor

Suqiao Yang

Collaborators

China-Japan Friendship Hospital, Beijing Anzhen Hospital

Enrollment target

~68 participants

Started

March 2025

Primary completion

October 2026

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.